Publication date: Jul 08, 2025
The effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation and plasticity: potential mechanistically-informed therapeutics in the treatment and prevention of mental disorders. A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: target engagement and rationale for the development in mental disorders. The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders. Binge eating in adults with mood disorders: results from the International Mood Disorders Collaborative Project. A systematic review on the role of glucagon-like peptide-1 receptor agonists on alcohol-related behaviors: potential therapeutic strategy for alcohol use disorder. Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review. Glucagon-like peptide-1 receptor agonists and risk for suicidal ideation and behaviors in U. S. older adults with type 2 diabetes: a target trial emulation study.
| Concepts | Keywords |
|---|---|
| Bloomgarden | Agonists |
| Canada | Al |
| Pilot | Cns |
| Psychopharmacology | Disorder |
| Disorders | |
| Eg | |
| Glp | |
| Glucagon | |
| Mental | |
| Peptide | |
| Psychiatric | |
| Ras | |
| Receptor | |
| Target | |
| Treatment |